S
Spartia Therapeutics develops novel therapies that specifically target RNA pathways implicated in cancer progression. The company focuses on creating precision medicines designed to modulate gene expression at the RNA level for therapeutic benefit. This approach aims to deliver highly specific and potent treatments for various oncological indications.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Spartia Therapeutics develops novel therapies that specifically target RNA pathways implicated in cancer progression. The company focuses on creating precision medicines designed to modulate gene expression at the RNA level for therapeutic benefit. This approach aims to deliver highly specific and potent treatments for various oncological indications.